Dana-Farber Cancer Institute

dfci.harvard.edu
+1 866 408 3324

Dana-Farber Cancer Institute

450 Brookline Avenue
02215 Boston
USA
+1 866 408 3324
dfci.harvard.edu
Profile News

About Dana-Farber Cancer Institute

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research.

Read more about Dana-Farber Cancer Institute
Facts about Dana-Farber Cancer Institute
  • Industry : Pharma

News about Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

16-May-2023 | science

AI predicts future pancreatic cancer

AI model spots those at highest risk for up to three years before diagnosis

Read news
Dana-Farber Cancer Institute

09-Jul-2021 | science

Buttoned Up Biomolecules

Click reaction for living systems: bioorthogonal hydroamination of activated linear alkynes

Read news
Dana-Farber Cancer Institute

03-Apr-2020 | science

New blood test detects wide range of cancers

Test proved able to detect and indicate site of dozens of types of cancer with high accuracy

Read news
Dana-Farber Cancer Institute

18-May-2016 | science

New cancer immunotherapy approach combines tumor fighting power with fewer side effects

Basic research into the dual nature of certain immune system cells has set the stage for a new approach to cancer immunotherapy that avoids some of the ...

Read news
Dana-Farber Cancer Institute

14-Jul-2015 | business & finance

INTEGRA announces $10,000 contribution to Boston’s Dana-Farber Cancer Institute

Following the launch of its limited edition PIPETGIRL pink pipette controller in support of breast cancer research earlier this year - INTEGRA announced it ...

Read news
Dana-Farber Cancer Institute

15-Jul-2014 | science

Antibody halts cancer-related wasting condition

Study pinpoints a molecular cause of cachexia, and hints at a potential treatment

Read news
Dana-Farber Cancer Institute

13-Jun-2013 | science

New sickle cell anemia therapy advances to Phase II clinical trials

Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana ...

Read news
Dana-Farber Cancer Institute

02-May-2013 | science

Belfer Institute and Evotec establish collaboration in oncology

The Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute and Evotec AG (EVT) announced a research collaboration aimed at discovering ...

Read news
Show more news about Dana-Farber Cancer Institute

Here you will find Dana-Farber Cancer Institute